FDA Inspection
GlaxoSmithKline BiologicalsGlaxoSmithKline Biologicals – FDA Inspection, Aug 5, 2025
Record Details
This FDA Inspection record concerns GlaxoSmithKline Biologicals, with an inspection on August 5, 2025, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · 7dbd6c72-5fb2-40c1-b76c-528641fc7782
Inspection Facts
- Inspection number
- 1280789
- FDA center
- Biologics
Other FDA inspections of GlaxoSmithKline Biologicals
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 8, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for GlaxoSmithKline Biologicals
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.